Polar Asset Management Partners’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-26,350
Closed -$880K 294
2016
Q2
$880K Sell
26,350
-42,160
-62% -$1.35M 0.04% 210
2016
Q1
$1.93M Buy
+68,510
New +$1.96M 0.08% 167

Other funds holding PFE

Polar Asset Management Partners's PFE Position: Q3 2024 in Review

Polar Asset Management Partners sold out of Pfizer (PFE) in Q3 2024, closing a stake of 54,500 shares — an estimated $1.52M sold.

Polar Asset Management Partners first reported a position in PFE in Q3 2015 and held it in 4 quarters. The position peaked at $77.3M in Q4 2017. 2,910 funds tracked by Wall St. Rank hold PFE as of Q3 2024.

  • Polar Asset Management Partners reported no remaining Pfizer position as of Q3 2024 after selling out during the quarter.
  • Polar Asset Management Partners sold 54,500 Pfizer shares in Q3 2024, an estimated $1.52M.
  • Polar Asset Management Partners first reported a position in Pfizer in Q3 2015 and held it in 4 quarters.
  • Polar Asset Management Partners's Pfizer position peaked at $77.3M in Q4 2017.
  • 2,910 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.

Based on Polar Asset Management Partners's 13F filing for Q3 2024, filed 14 Nov 2024.